Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor

J. Michael Mathis(University of North Texas Health Science Center), James A. Cardelli(Louisiana State University Health Sciences Center Shreveport)

Oncolytic Virotherapy

September 1, 2015

10.2147/ov.s87369

Cited by 7

Related Papers

Supporting a Role for the GTPase Rab7 in Prostate Cancer Progression

|PLoS ONE|2014|72

The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer <i>in vitro</i> and xenograft formation and growth <i>in vivo</i>

|Oncotarget|2016|65

The Polyphenols (−)-Epigallocatechin-3-Gallate and Luteolin Synergistically Inhibit TGF-β-Induced Myofibroblast Phenotypes through RhoA and ERK Inhibition

|PLoS ONE|2014|50

Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity

|Oncotarget|2016|25

Lysosome trafficking is necessary for EGF-driven invasion and is regulated by p38 MAPK and Na+/H+ exchangers

|BMC Cancer|2017|15